ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

A CROSS SECTIONAL STUDY TO ANALYZE RISK OF PNEUMONIA IN OBSTRUCTIVE LUNG DISEASE AMONG LOCAL POPULATION OF SARGODHA

AUTHORS:

Dr. Sadaf ul Hira, Dr Zubair Saleem Virk, Dr Momal

ABSTRACT:

Abstract: Inhaled corticosteroids (ICS) are widely used in high doses in the management of obstructive lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). Current asthma treatment guidelines recommend stepping up the ICS dose if lack of control persists. Objectives of the study: The main objective of the study is to analyze the risk of pneumonia in obstructive lung disease among local population of Pakistan. Methodology of the study: This study was conducted at DHQ Sargodha in March 2019. This study was done with the permission of ethical committee. For this purpose we select 50 patients of pneumonia for further analysis. The patients of both gender were selected for this study. Diagnosis of pneumonia: (i) unconfirmed i.e. all unique patients with codes for pneumonia and, (ii) confirmed by chest radiograph or resulting in hospitalization within one month of pneumonia diagnosis. Result: Significant differences were observed between patients who received extra-fine versus fine-particle COPD in the demographics and baseline characteristics, as shown in Table 1. The COPD treatments prescribed to patients before and at step-up are shown in S1 Table in the supporting information. Conclusion: In conclusion, the COPD exacerbation rate was higher among the patients who had a history of pneumonia or a high rate of COPD exacerbation in the preceding period of 1 year. Key Words: Pneumonia, obstructive lung disease, inhaled corticosteroids.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.